Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial Mediterranean fever.

Fatos Onen1

  • 1Division of Immunology and Rheumatology, Department of Internal Medicine, Dokuz Eylul University School of Medicine, 35340, Balcova-Izmir, Turkey. fatos.onen@deu.edu.tr

Rheumatology International
|November 12, 2005
PubMed
Summary

Familial Mediterranean fever (FMF) is an inherited inflammatory disorder causing recurrent fever and inflammation. Colchicine therapy effectively manages FMF symptoms and prevents severe complications like kidney failure from amyloidosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of Vascular Interventions in Takayasu Arteritis and the Role of Biologic Therapy: A Multicenter Retrospective Study.

International journal of rheumatic diseases·2026
Same author

Risk of intestinal involvement in mucocutaneous-onset Behçet's disease: data from the AIDA network registry.

Frontiers in immunology·2026
Same author

Screening of osteoporosis in patients with ANCA-associated vasculitis (AAV) is quite low: results from a country-wide study.

Internal and emergency medicine·2026
Same author

Building bridges for early-career rheumatologists in Türkiye: insights from the Turkish Society for Rheumatology-young rheumatologists.

Rheumatology (Oxford, England)·2026
Same author

Venous Thromboembolism May Be Increased in the Early Phases of ANCA-Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR-VaS Experience.

International journal of rheumatic diseases·2025
Same author

Factors associated with diagnostic delay and specialty consultation patterns in systemic sclerosis: A cross-sectional study.

Rheumatology international·2025

Area of Science:

  • Genetics
  • Immunology
  • Rheumatology

Background:

  • Familial Mediterranean fever (FMF) is a prevalent hereditary autoinflammatory disease.
  • Characterized by recurrent episodes of fever and serositis, FMF affects specific ethnic groups.
  • Caused by mutations in the MEFV gene, encoding pyrin, which regulates inflammatory pathways.

Purpose of the Study:

  • To summarize the key aspects of Familial Mediterranean Fever.
  • To highlight the genetic basis, clinical manifestations, and complications of FMF.
  • To discuss the established risk factors for amyloidosis and the efficacy of colchicine treatment.

Main Methods:

  • Review of existing literature on Familial Mediterranean Fever.
  • Analysis of genetic mutations (MEFV gene) and their role in pyrin function.
  • Identification of risk factors for amyloidosis and evaluation of colchicine's therapeutic effects.

Main Results:

  • FMF is an autosomal recessive disorder linked to MEFV gene mutations.
  • Pyrin dysfunction leads to uncontrolled inflammation, with amyloidosis being a major complication.
  • M694V homozygosity, male gender, and SAA1 genotype are risk factors for amyloidosis.

Conclusions:

  • Colchicine is the primary treatment for FMF, achieving remission and reducing attack frequency.
  • Colchicine therapy is crucial for preventing and halting the progression of renal amyloidosis.
  • Understanding FMF genetics and risk factors aids in managing this inflammatory disease and its complications.

Related Experiment Videos